1 terminated, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow Ham: new trials by email Literature Review of Ham trials Research Report on Ham
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management Human Amniotic Membrane, Conventional/Standard treatment - Osteonecrosis Due to Drugs, Jaw | Phase 2 | Unknown | Centre Hospitalier Universitaire de Besancon | 66 | 2023-09-22 | 2024-09-19 |
| Immunotherapy Study for Patients With Stage IV Melanoma HyperAcute®-Melanoma (HAM) Immunotherapy, Ipilimumab, Pembrolizumab - Stage IV Melanoma, Metastatic Melanoma | Phase 2 | Terminated | NewLink Genetics Corporation | 47 | 2014-06-01 | 2023-04-18 |
Melanoma (1)
Centre Hospitalier Universitaire de Besancon (1) · NewLink Genetics Corporation (1)
France (1) · United States (1)